News|Articles|May 28, 2026
Gameto: Accelerating Global Clinical Studies in 3 Weeks
Author(s)Castor
See how Gameto, a biotechnology company focused on redefining women's health, leveraged Castor’s EDC and decentralized capabilities to successfully launch their global studies in just 3 weeks. Discover how a lean biotech team scaled their research rapidly across multiple international sites.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
2
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
3
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5